Incremental costs of chemotherapy - Pharmacoeconomic results from the prospective adjuvant WSG-AGO Intergroup EC-DOC trial comparing an anthracycline-docetaxel sequence to CMF in node-positive breast cancer
Dokumenttyp:
Meeting Abstract
Autor(en):
Braun, M; Jacobs, VR; Wagenpfeil, S; Sattler, D; Harbeck, N; Nitz, U; Bernard, R; Kuhn, W; Ihbe-Heffingers, A